LYME DISEASE BORRELIA BURGDORFERI DNA QUALITATIVE REAL TIME PCR Test
Test Name: LYME DISEASE BORRELIA BURGDORFERI DNA QUALITATIVE REAL TIME PCR Test
Components: Price 3460.0 AED
Sample Condition: 2 mL (1 mL min.) CSF / Synovial Fluid in a sterile screw capped container. Ship refrigerated or frozen. Duly filled Test Send Out Consent Form is mandatory.
Report Delivery: Sample by 7th of the month; Report after 2-3 weeks
Method: Real Time PCR
Test type: Infections
Doctor: Physician
Test Department: OS
Pre Test Information: Duly filled Test Send Out Consent Form is mandatory.
Test Details
The Lyme disease (Borrelia burgdorferi) DNA qualitative real-time PCR test is a diagnostic tool used to detect the presence of Borrelia burgdorferi, the bacterium responsible for causing Lyme disease. This test uses the polymerase chain reaction (PCR) technique to amplify and detect specific DNA sequences of the bacterium.
During the test, a sample is collected from the patient, typically a blood sample, and the DNA is extracted from the sample. The PCR technique is then used to amplify specific regions of the Borrelia burgdorferi DNA, if present in the sample. This amplification process allows for the detection and quantification of the DNA in real-time.
The real-time PCR test is highly sensitive and specific, allowing for the detection of even small amounts of Borrelia burgdorferi DNA in the sample. It can be used to confirm a diagnosis of Lyme disease in patients with symptoms consistent with the disease or to monitor the effectiveness of treatment.
It is important to note that the PCR test detects the presence of Borrelia burgdorferi DNA, not the presence of active infection or the presence of antibodies. Therefore, it is possible for the test to yield a positive result in individuals who have been previously infected with Lyme disease but are no longer actively infected.
Overall, the Lyme disease DNA qualitative real-time PCR test is a valuable tool in the diagnosis and management of Lyme disease, allowing for early detection and appropriate treatment.
| Test Name | LYME DISEASE BORRELIA BURGDORFERI DNA QUALITATIVE REAL TIME PCR Test |
|---|---|
| Components | |
| Price | 3460.0 AED |
| Sample Condition | 2 mL (1 mL min.) CSF \/ Synovial Fluid in a sterile screw capped container. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory. |
| Report Delivery | Sample by 7th of the month; Report after 2??3 weeks |
| Method | Real Time PCR |
| Test type | Infections |
| Doctor | Physician |
| Test Department: | OS |
| Pre Test Information | Duly filled Test Send Out Consent Formis mandatory. |
| Test Details | The Lyme disease (Borrelia burgdorferi) DNA qualitative real-time PCR test is a diagnostic tool used to detect the presence of Borrelia burgdorferi, the bacterium responsible for causing Lyme disease. This test uses the polymerase chain reaction (PCR) technique to amplify and detect specific DNA sequences of the bacterium. During the test, a sample is collected from the patient, typically a blood sample, and the DNA is extracted from the sample. The PCR technique is then used to amplify specific regions of the Borrelia burgdorferi DNA, if present in the sample. This amplification process allows for the detection and quantification of the DNA in real-time. The real-time PCR test is highly sensitive and specific, allowing for the detection of even small amounts of Borrelia burgdorferi DNA in the sample. It can be used to confirm a diagnosis of Lyme disease in patients with symptoms consistent with the disease or to monitor the effectiveness of treatment. It is important to note that the PCR test detects the presence of Borrelia burgdorferi DNA, not the presence of active infection or the presence of antibodies. Therefore, it is possible for the test to yield a positive result in individuals who have been previously infected with Lyme disease but are no longer actively infected. Overall, the Lyme disease DNA qualitative real-time PCR test is a valuable tool in the diagnosis and management of Lyme disease, allowing for early detection and appropriate treatment. |
